US Department of Health and Human Services. The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
RoomR.Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond [published online ahead of print November 3, 2013]. Addiction. doi: 10.1111/add.12355.
4.
EddyM.Medical marijuana: Review and analysis of federal and state policies (RL33211). CRS Report for Congress. Congressional Research Service. April 2, 2010. https://www.fas.org/sgp/crs/misc/RL33211.pdf. Accessed January 24, 2014.
5.
LindseyWT, StewartD, ChildressD.Drug interactions between common illicit drugs and prescription therapies. Am J Drug Alcohol Abuse. 2012:38(4):334–343.
6.
BorgeltLM, FransonKL, NussbaumAM, WangGS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013;33(2):195–209.
7.
StoutSM, CiminoNM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: A systematic review [published online ahead of print October 25, 2013]. Drug Metab Rev.
8.
GrinspoonL.On the pharmaceuticalization of marijuana. Int J Drug Policy. 2001;12:377–383.
9.
SeamonMJ, FassJA, Maniscalco-FeichtlM, Abu-ShraieNA. Medical marijuana and the developing role of the pharmacist. Am J Health Syst Pharm2007;64:1037–1044.